Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-01 · accession 0001127602-23-029012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-06 | 2023-12-04 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $1.39 | -42.4K | 676.8K | -6% | -$58.9K |
| DM | 2023-12-06 | 2023-12-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +85.0K | 717.6K | +13% | — |
| DM | 2023-12-06 | 2023-12-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -85.0K | 706.9K | -11% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-04 | S | D | 42,402 | $1.39 | 676,844 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-12-01 | M | A | 1,634 | — | 719,246 | D | — | — | (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 3 | Common | Class A Common Stock | 2023-12-01 | M | A | 65,281 | — | 699,487 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| 4 | Common | Class A Common Stock | 2023-12-01 | M | A | 18,125 | — | 717,612 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| 5 | Derivative | Class B Common Stock | 2023-12-01 | M | D | 1,634 | — | 635,231 | D | — · — to — | 1,634 Class A Common Stock | (F6) Includes shares of Class B Common Stock that are subject to vesting conditions. (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2023-12-01 | M | D | 65,281 | — | 974,067 | D | — · — to — | 65,281 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| 7 | Derivative | Restricted Stock Units | 2023-12-01 | M | D | 18,125 | — | 706,875 | D | — · — to — | 18,125 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. (F5) The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |